Medicine and Dentistry
Patient
100%
Platelet
78%
Edoxaban
41%
Von Willebrand Factor
39%
Therapeutic Procedure
33%
Combination Therapy
25%
Bleeding
24%
Haemophilia A
23%
Inpatient
23%
Plasma
22%
Coagulation
20%
Anticoagulation
19%
Percutaneous Endoscopic Gastrostomy
17%
Atrial Fibrillation
17%
Fibrinogen
16%
Assay
15%
Von Willebrand Factor Cleaving Proteinase
14%
Portal Vein Thrombosis
14%
Child
14%
Essential Thrombocythaemia
13%
Thrombin
12%
Recombinant Blood Clotting Factor 8
12%
Venous Thromboembolism
12%
Serositis
12%
Thrombocyte Function
12%
Follow up
11%
Blood Clotting Factor 8
11%
Heparin
11%
Thrombotic Thrombocytopenic Purpura
10%
Multiple Myeloma
10%
Polyethylene Glycol
10%
Gray Platelet Syndrome
10%
Diabetes Mellitus
10%
Diagnosis
10%
Complication
10%
In Vitro
10%
Haemophilia
10%
Prophylaxis
9%
Acetylsalicylic Acid
9%
Protein
9%
Thrombosis
9%
Analysis
9%
Antithrombotic
9%
Myelofibrosis
9%
Interleukin 6
9%
Diseases
8%
Collagen
8%
Pharmacodynamics
8%
Blood
8%
Chronic Liver Disease
8%
Biochemistry, Genetics and Molecular Biology
Von Willebrand Factor
93%
Thrombin
83%
Platelet
43%
Mutation
34%
Fibrinogen
31%
Protein
30%
Peptide
24%
ADAMTS13
24%
ADAMTS
20%
Factor X
20%
Nested Gene
19%
Mutant
19%
Lysozyme
18%
Coagulation
17%
Hemoglobin
16%
Prothrombin
16%
High-Performance Liquid Chromatography
15%
Von Willebrand Factor
15%
Enzymatic Hydrolysis
13%
Development
12%
Thrombotic Microangiopathy
12%
Metalloproteinase
12%
Hirudin
12%
Heparin
11%
Wild Type
11%
Peptide Sequence
10%
Factor XI
10%
Alpha Oxidation
10%
Thrombocyte Aggregation
10%
Enzymatic Activity
10%
Exosite
10%
Disintegrin
10%
Recognition
9%
Ristocetin
9%
Self Concept
9%
Protein C
9%
Thrombomodulin
8%
Nonsense-Mediated Decay
8%
Protease
8%
Molecule
8%
Conformational Change
8%
Binding Site
8%
Indoleamine 2,3-dioxygenase
8%
Messenger RNA
8%
Hemostasis
8%
Molecular Dynamics
7%
Thrombocyte Function
7%
Alternative Splicing
7%
Phenotype
7%
Protease-Activated Receptor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
34%
Edoxaban
32%
Anticoagulant Agent
31%
Acetylsalicylic Acid
20%
Atrial Fibrillation
19%
Thrombin
19%
Thrombotic Thrombocytopenic Purpura
17%
Venous Thromboembolism
14%
Adenosine Diphosphate
11%
Normal Human
11%
Recombinant Blood Clotting Factor 8
10%
Thromboxane
10%
Bleeding
9%
Agonist
8%
Indoleamine 2,3 Dioxygenase
8%
Apixaban
7%
Antivitamin K
7%
Heparin
7%
Hemophilia A
7%
Enzyme
7%
Pathogenesis
7%
Fibrinogen
7%
Rivaroxaban
6%
Flow Cytometry
6%
Vaccine
6%
Hemophilia
6%
Thromboembolism
6%
Kynurenine
6%
Thrombosis
6%
Protein
5%
Peptide
5%
Thrombin Inhibitor
5%
Procoagulant
5%
D Dimer
5%
Gray Platelet Syndrome
5%
Recombinant Blood Clotting Factor 8
5%
Haemophilia A
5%
Morbidity
5%
Malignant Neoplasm
5%
Fibroblast Growth Factor 2
5%
Drug
5%
